Avid Bioservices Inc (CDMO)

[YODA KNOWS]

Beststocksdaily.com Issues Investment Alert On
PINK:WMIH
PINK:BMSN
PINK:BGMO
NASDAQ:PPHM

Beststocksdaily.com Is announcing Investment Highlights on
WMI HOLDINGS (PINK:WMIH)
Bio Matrix Scientific Group Inc (PINK:BMSN)
Bergamo Acquisition Corp(PINK:BGMO)
Peregrine Pharmaceuticals(NASDAQ:PPHM)

Los Angeles, CA, Jan 02, 2013 (eTeligis.com via COMTEX) WMI HOLDINGS (PINKSHEETS:WMIH) jumped up 1.14% to $0.89. The Company files(8-K) disclosing regulation FD disclosure, financial statements and exhibits. The 52-week range for the stock is $0.40 and $1.14. The Company has Price/Sales ratio of 0.05 and Price/Book ratio of 2.37. The 50-Day Moving Average and 200-Day Moving Average prices is $0.57 and $0.52 respectively. The Company together with its subsidiaries operates as a consumer and small business banking company in the United States.
Will WMIH Move Higher After Today's Sudden Selling Activities?

Don't Miss The Free Trend Analysis here
http://beststocksdaily.com/p2/index.php?company=WMIH

Bio Matrix Scientific Group Inc (PINKSHEETS:BMSN) among the gainers and the stock is up 13.33% to $0.0017 on a traded volume of 8.19 million shares. The 52-week range for the stock is $0.02 and $0.18. The 50-Day Moving Average and 200-Day Moving Average prices is $0.03 and $0.04 respectively. The Company is in the business of designing, developing and marketing medical devices, specifically disposable instruments used in stem cell extraction and tissue transfer procedures and operating cryogenic cellular storage facilities, specifically stem cell banking facilities.
How Should Investors Trade BMSN After The Recent Momentum,
Find Out Here http://beststocksdaily.com/p2/index.php?company=BMSN

Bergamo Acquisition Corp(PINKSHEETS:BGMO)soared 13.04% to $0.0260.The Company has received the OTC Markets "Current Information" designation and symbol. Bergamo Acquisition has filed its current financial statements and disclosure documents on the OTC Markets website.Bergamo Acquisition Corp is a global investor targeting a diversified portfolio of large corporate and middle-market companies for sole acquisition and co-investment.

Get Free Special Trend Analysis OnBGMO Here http://beststocksdaily.com/p2/index.php?company=BGMO

Peregrine Pharmaceuticals(NASDAQ:PPHM) declined 2.44% to $1.20. Levi & Korsinsky LLP is investigating potential claims on behalf of purchasers of Peregrine Pharmaceuticals Inc securities concerning possible breaches of fiduciary duty in connection with the disclosure of the discovery of major discrepancies in the treatment group of its Bavituxmab Phase II Second-Line Non-Small Cell Lung Cancer Trial. Zacks increased the rating on the stock from a neutral to outperform in a research report. The firm currently has $1.50 price target on the stock.

Get Free Special Trend Analysis On PPHM Here
http://beststocksdaily.com/p2/index.php?company=PPHM